What is known about esketamine hydrochloride passing into human breast milk?

Whether esketamine hydrochloride passes into human milk is unknown; animal data show milk excretion, infant risk cannot be excluded, and a decision is required between stopping breast-feeding or stopping/abstaining from Spravato therapy, considering breast-feeding benefits for the child and treatment benefits for the woman.